Yitzchak Tessler

Founder & Owner at Ncmusa

Yitzchak Tessler's Professional Contact Details

Email (Verified)

****@ncm-usa.com

Get Email Address

(212) 719-2322

Location

New York, New York, US

Company

Ncmusa

Person Seniority

owner

Person Functions

entrepreneurship

Yitzchak Tessler's Current Company Details

Ncmusa

New York, US • 6 Employees

pharmaceuticals

NCM's strategy is to develop the most advanced PET radiopharmaceutical manufacturing and distribution network. The market for molecular imaging agents in the United States currently exceeds $1.3 billion annually and is expected to grow to over $3 billion by 2020. Most existing manufacturing facilities are outdated, and, due to new FDA regulations, they lack the capacity to meet demands for new compounds while continuing to produce their current line of radiopharmaceuticals. There are approximately 60 new radioactive biomarkers now undergoing clinical trials in the United States. Many of these isotopes will emerge as new products during the next five years. The shortfall in existing production capacity supports our strategy for creating a new PET radiopharmaceutical manufacturing facility. NCM has signed a technology procurement agreement with General Electric (GE) for cyclotron and associated manufacturing technologies. We are introducing patented proprietary technologies from Posi-Med, a first in the PET industry and introducing an innovative technology designed to exceed the newly announced FDA 212 requirements. Introduction of these technologies will establish NCM as a leader in PET manufacturing in the New York area. Early-stage strategic alliances are NCM's core competency and the driver of its long term success. The Company's business strategy relies on its ability to provide a continuous pipeline of novel imaging agents and its relationships with leading pharmaceutical companies and research universities. To supplement its internal product development capabilities, NCM will maintain ongoing sponsored research with world-class scientists. We will expand collaborative relationships with universities and hospitals to identify promising new imaging technologies. NCM will acquire the exclusive licensing rights to discoveries made by university and hospital partners where appropriate.

Founded Year

2011

Organization Website

ncm-usa.com

Organization Languages

English

Organization Revenue

7000

Current Technologies

microsoft-iis

asp net

gmail